The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: Results from 2733 consecutive patients

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 1, 2011, Pages 75-81

  Chambon, Guillaume ^a,c   Alovisetti, Caroline ^a   Idoux Louche, Catherine ^b   Reynaud, Christophe ^a   Rodier, Michel ^a   Guedj, Anne Marie ^a   Chapuis, Héliette ^a   Lallemant, Jean Gabriel ^a,c   Lallemant, Benjamin ^a,c  

^a NÎMES UNIVERSITY HOSPITAL   (France)

^b Service d'Orl   (France)

^c UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; PENTAGASTRIN;

ADULT; AGED; ARTICLE; CALCITONIN BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERCALCITONINEMIA; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THYROID MEDULLARY CARCINOMA; THYROID NODULE; THYROID SURGERY; THYROIDECTOMY;

EID: 78650879117     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0162     Document Type: Article

References (26)

1. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109-142
2. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803
3. Cheung K, Roman SA, Wang TS, Walker HD, Sosa JA 2008 Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis. J Clin Endocrinol Metab 93:2173-2180
4. Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A, Pacini F 2004 Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 89:163-168
5. Gharib H, Papini E, Valcavi R, Baskin HJ, Crescenzi A, Dottorini ME, Duick DS, Guglielmi R, Hamilton Jr CR, Zeiger MA, Zini M 2006 American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 12:63-102
6. Niccoli P, Conte-Devolx B, Lejeune PJ, Carayon P, Henry JF, Roux F, Wion-Barbot N, Bigorgne JC 1996 [Hypercalcitoninemia in conditions other than medullary cancers of the thyroid]. Ann Endocrinol 57:15-21
7. Barbot N, Calmettes C, Schuffenecker I, Saint-André JP, Franc B, Rohmer V, Jallet P, Bigorgne JC 1994 Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. J Clin Endocrinol Metab 8:114-120 (Pubitemid 24983132)
8. Wion-Barbot N, Schuffenecker I, Niccoli P, Conte-Devolx B, Lecomte P, Houdent C, Bigorgne JC, Modigliani E 1997 Results of the calcitonin stimulation test in normal volunteers compared with genetically unaffected members of MEN 2A and familial medullary thyroid carcinoma families. Ann Endocrinol 58:302-308
9. Evans DB, Fleming JB, Lee JE, Cote G, Gagel RF 1999 The surgical treatment of medullary thyroid carcinoma. Semin Surg Oncol 16:50-63
10. Weber T, Schilling T, Frank-Raue K, Colombo-Benkmann M, Hinz U, Ziegler R, Klar E 2001 Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas. Surgery 130:1044-1049
11. Scollo C, Baudin E, Travagli JP, Caillou B, Bellon N, Leboulleux S, Schlumberger M 2003 Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 88:2070-2075
12. Guyétant S, Rousselet MC, Durigon M, Chappard D, Franc B, Guerin O, Saint-André JP 1997 Sex-related C cell hyperplasia in the normal human thyroid: a quantitative autopsy study. J Clin Endocrinol Metab 82:42-47
13. Niccoli P, Wion-Barbot N, Caron P, Henry JF, de Micco C, Saint Andre JP, Bigorgne JC, Modigliani E, Conte-Devolx B 1997 Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. J Clin Endocrinol Metab 82:338-341
14. Bugalho MJ, Santos JR, Sobrinho L 2005 Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement. J Surg Oncol 91:56-60
15. Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, Miccoli P, Pinchera A 1994 Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 78:826-829
16. Peix JL, Braun P, Saadat M, Berger N, El Khazen M, Mancini F 2000 Occult micro medullary thyroid carcinoma: therapeutic strategy and follow-up. World J Surg 24:1373-1376
17. Scheuba C, Kaserer K, Bieglmayer C, Asari R, Riss P, Drosten R, Niederle B 2007 Medullary thyroid microcarcinoma recommendations for treatment - a single-center experience. Surgery 142:1003-1010; discussion 1010e1-e3.
18. Iacobone M, Niccoli-Sire P, Sebag F, De Micco C, Henry JF 2002 Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels. World J Surg 26:886-890
19. Vierhapper H, Niederle B, Bieglmayer C, Kaserer K, Baumgartner-Parzer S 2005 Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid 15:1267-1272
20. Mirallié E, Iacobone M, Sebag F, Henry JF 2004 Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin. Eur J Surg Oncol 30:790-795
21. Hamy A, Pessaux P, Mirallié E, Mucci-Hennekinne S, Gibelin H, Mor-Martinez C, de Calan L, Ronceray J, Kraimps JL 2005 Central neck dissection in the management of sporadic medullary thyroid microcarcinoma. Eur J Surg Oncol 31:774-777
22. Scheuba C, Kaserer K, Weinhausl A, Pandev R, Kaider A, Passler C, Prager G, Vierhapper H, Haas OA, Niederle B 1999 Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. Surgery 126:1089-1095; discussion 1096
23. Elisei R 2008 Routine serum calcitonin measurement in the evaluation of thyroid nodules. Best Pract Res Clin Endocrinol Metab 22:941-953
24. Scheuba C, Kaserer K, Moritz A, Drosten R, Vierhapper H, Bieglmayer C, Haas OA, Niederle B 2009 Sporadic hypercalcitoninemia: clinical and therapeutic consequences. Endocr Relat Cancer 16:243-253
25. Rink T, Truong PN, Schroth HJ, Diener J, Zimny M, Grünwald F 2009 Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease. Thyroid 19:327-332
26. Gibelin H, Essique D, Jones C, Levillain P, Maréchaud R, Kraimps JL 2005 Increased calcitonin level in thyroid nodules without medullary carcinoma. Br J Surg 92:574-578